Bulliard J-L, Ducros C, Jemelin C, Arzel B, Fioretta G, Levi F
Cancer Epidemiology Unit, University Institute of Social and Preventive Medicine (IUMSP), Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
Ann Oncol. 2009 Jul;20(7):1199-202. doi: 10.1093/annonc/mdn770. Epub 2009 Mar 12.
Detailed comparison of effectiveness between organised and opportunistic mammography screening operating in the same country has seldom been carried out.
Prognostic indicators, as defined in the European Guidelines, were used to evaluate screening effectiveness in Switzerland. Matching of screening programmes' records with population-based cancer registries enabled to compare indicators of effectiveness by screening and detection modality (organised versus opportunistic screening, unscreened, interval cancers). Comparisons of prognostic profile were also drawn with two Swiss regions uncovered by service screening of low and high prevalence of opportunistic screening, respectively.
Opportunistic and organised screening yielded overall little difference in prognostic profile. Both screening types led to substantial stage shifting. Breast cancer prognostic indicators were systematically more favourable in Swiss regions covered by a programme. In regions without a screening programme, the higher the prevalence of opportunistic screening, the better was the prognostic profile.
Organised screening appeared as effective as opportunistic screening. Mammography screening has strongly influenced the stage distribution of breast cancer in Switzerland, and a favourable impact on mortality is anticipated. Extension of organised mammography screening to the whole of Switzerland can be expected to further improve breast cancer prognosis in a cost-effective way.
在同一国家对有组织的和机会性的乳腺钼靶筛查的有效性进行详细比较的研究很少。
采用欧洲指南中定义的预后指标来评估瑞士的筛查有效性。将筛查项目记录与基于人群的癌症登记处进行匹配,从而能够按筛查和检测方式(有组织筛查与机会性筛查、未筛查、间期癌)比较有效性指标。还分别与瑞士两个未进行服务筛查的地区进行了预后特征比较,这两个地区机会性筛查的患病率分别为低和高。
机会性筛查和有组织的筛查在预后特征上总体差异不大。两种筛查类型都导致了显著的分期转移。在有筛查项目覆盖的瑞士地区,乳腺癌的预后指标在系统上更有利。在没有筛查项目的地区,机会性筛查的患病率越高,预后特征越好。
有组织的筛查似乎与机会性筛查一样有效。乳腺钼靶筛查对瑞士乳腺癌的分期分布产生了强烈影响,预计对死亡率有积极影响。可以预期,将有组织的乳腺钼靶筛查扩展到整个瑞士能够以具有成本效益的方式进一步改善乳腺癌的预后。